Novartis Suffers Third Clinical Setback in a Week; Shares Plunge 13% in Early US Trading, Erasing Over $40 Billion in Market Value — BigGo Finance
Swiss pharmaceutical giant Novartis faced heavy selling after the US market opened on September 8, with shares plunging…